vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与WEYCO GROUP INC（WEYS）财务数据对比。点击上方公司名可切换其他公司
WEYCO GROUP INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$76.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -4.6%），WEYCO GROUP INC自由现金流更多（$23.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.6%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
韦科集团是一家美国鞋履企业，主要从事鞋履产品的设计、营销与分销业务，旗下拥有Florsheim、Nunn Bush、Stacy Adams、BOGS、Rafters、Umi等多个品牌。集团聚焦北美市场的批发与零售分销业务，通过一系列并购整合发展至今。
PBYI vs WEYS — 直观对比
营收规模更大
WEYS
是对方的1.0倍
$75.5M
营收增速更快
PBYI
高出32.3%
-4.6%
自由现金流更多
WEYS
多$8.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $76.8M |
| 净利润 | — | $8.7M |
| 毛利率 | 69.3% | 44.1% |
| 营业利润率 | 22.7% | 13.3% |
| 净利率 | — | 11.3% |
| 营收同比 | 27.7% | -4.6% |
| 净利润同比 | — | -13.1% |
| 每股收益（稀释后） | $0.26 | $0.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIWEYS
| Q4 25 | $75.5M | $76.8M | ||
| Q3 25 | $54.5M | $73.1M | ||
| Q2 25 | $52.4M | $58.2M | ||
| Q1 25 | $46.0M | $68.0M | ||
| Q4 24 | $59.1M | $80.5M | ||
| Q3 24 | $80.5M | $74.3M | ||
| Q2 24 | $47.1M | $63.9M | ||
| Q1 24 | $43.8M | $71.6M |
净利润PBYIWEYS
| Q4 25 | — | $8.7M | ||
| Q3 25 | $8.8M | $6.6M | ||
| Q2 25 | $5.9M | $2.3M | ||
| Q1 25 | $3.0M | $5.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | $20.3M | $8.1M | ||
| Q2 24 | $-4.5M | $5.6M | ||
| Q1 24 | $-4.8M | $6.7M |
毛利率PBYIWEYS
| Q4 25 | 69.3% | 44.1% | ||
| Q3 25 | 77.7% | 40.7% | ||
| Q2 25 | 76.5% | 43.3% | ||
| Q1 25 | 77.1% | 44.6% | ||
| Q4 24 | 76.4% | 47.9% | ||
| Q3 24 | 63.9% | 44.3% | ||
| Q2 24 | 77.4% | 43.9% | ||
| Q1 24 | 75.5% | 44.7% |
营业利润率PBYIWEYS
| Q4 25 | 22.7% | 13.3% | ||
| Q3 25 | 17.6% | 11.0% | ||
| Q2 25 | 12.7% | 6.7% | ||
| Q1 25 | 8.7% | 10.3% | ||
| Q4 24 | 22.6% | 14.3% | ||
| Q3 24 | 27.4% | 13.7% | ||
| Q2 24 | -4.6% | 10.4% | ||
| Q1 24 | -5.3% | 11.5% |
净利率PBYIWEYS
| Q4 25 | — | 11.3% | ||
| Q3 25 | 16.2% | 9.0% | ||
| Q2 25 | 11.2% | 3.9% | ||
| Q1 25 | 6.5% | 8.1% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | 25.2% | 10.8% | ||
| Q2 24 | -9.6% | 8.8% | ||
| Q1 24 | -11.0% | 9.3% |
每股收益（稀释后）PBYIWEYS
| Q4 25 | $0.26 | $0.91 | ||
| Q3 25 | $0.17 | $0.69 | ||
| Q2 25 | $0.12 | $0.24 | ||
| Q1 25 | $0.06 | $0.57 | ||
| Q4 24 | $0.40 | $1.04 | ||
| Q3 24 | $0.41 | $0.84 | ||
| Q2 24 | $-0.09 | $0.59 | ||
| Q1 24 | $-0.10 | $0.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $96.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $239.6M |
| 总资产 | $216.3M | $319.7M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIWEYS
| Q4 25 | $97.5M | $96.0M | ||
| Q3 25 | $94.4M | $72.9M | ||
| Q2 25 | $96.0M | $77.4M | ||
| Q1 25 | $93.2M | $71.5M | ||
| Q4 24 | $101.0M | $71.0M | ||
| Q3 24 | $96.7M | $75.5M | ||
| Q2 24 | $96.8M | $78.4M | ||
| Q1 24 | $107.2M | $78.3M |
总债务PBYIWEYS
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIWEYS
| Q4 25 | $130.3M | $239.6M | ||
| Q3 25 | $115.3M | $251.3M | ||
| Q2 25 | $104.7M | $248.1M | ||
| Q1 25 | $97.1M | $248.6M | ||
| Q4 24 | $92.1M | $245.6M | ||
| Q3 24 | $71.1M | $258.1M | ||
| Q2 24 | $48.5M | $251.2M | ||
| Q1 24 | $51.0M | $248.1M |
总资产PBYIWEYS
| Q4 25 | $216.3M | $319.7M | ||
| Q3 25 | $202.9M | $304.0M | ||
| Q2 25 | $194.9M | $300.9M | ||
| Q1 25 | $196.2M | $299.3M | ||
| Q4 24 | $213.3M | $324.1M | ||
| Q3 24 | $220.7M | $314.7M | ||
| Q2 24 | $205.0M | $303.8M | ||
| Q1 24 | $214.1M | $303.3M |
负债/权益比PBYIWEYS
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $24.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $23.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 30.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 2.76× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $35.5M |
8季度趋势，按日历期对齐
经营现金流PBYIWEYS
| Q4 25 | $14.4M | $24.0M | ||
| Q3 25 | $9.7M | $-1.1M | ||
| Q2 25 | $14.1M | $10.2M | ||
| Q1 25 | $3.6M | $4.1M | ||
| Q4 24 | $15.6M | $20.4M | ||
| Q3 24 | $11.0M | $-374.0K | ||
| Q2 24 | $1.0M | $3.3M | ||
| Q1 24 | $11.2M | $14.3M |
自由现金流PBYIWEYS
| Q4 25 | $14.4M | $23.1M | ||
| Q3 25 | $9.7M | $-1.3M | ||
| Q2 25 | $14.1M | $10.0M | ||
| Q1 25 | $3.6M | $3.7M | ||
| Q4 24 | $15.6M | $19.9M | ||
| Q3 24 | $11.0M | $-930.0K | ||
| Q2 24 | $1.0M | $3.2M | ||
| Q1 24 | — | $14.2M |
自由现金流率PBYIWEYS
| Q4 25 | 19.1% | 30.1% | ||
| Q3 25 | 17.7% | -1.8% | ||
| Q2 25 | 26.8% | 17.1% | ||
| Q1 25 | 7.7% | 5.5% | ||
| Q4 24 | 26.4% | 24.8% | ||
| Q3 24 | 13.7% | -1.3% | ||
| Q2 24 | 2.1% | 4.9% | ||
| Q1 24 | — | 19.8% |
资本支出强度PBYIWEYS
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | 0.0% | 0.2% |
现金转化率PBYIWEYS
| Q4 25 | — | 2.76× | ||
| Q3 25 | 1.10× | -0.17× | ||
| Q2 25 | 2.41× | 4.53× | ||
| Q1 25 | 1.21× | 0.74× | ||
| Q4 24 | — | 2.04× | ||
| Q3 24 | 0.54× | -0.05× | ||
| Q2 24 | — | 0.59× | ||
| Q1 24 | — | 2.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
WEYS
| Wholesale | $56.7M | 74% |
| Retail Segment | $13.3M | 17% |
| Other | $6.8M | 9% |
